Cancer patients urge rethink over treatment

Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects. But today the body that recommends what can and cant be paid for said it 'wasn't cost effective'.

Live updates

Patients urge rethink over cancer drug treatment

Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.

Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.

Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.

One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:

Advertisement

Back to top